Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01717248 · ClinicalTrials.gov registry record · Phase 1
Safety Study of GCS-100 to Treat Chronic Kidney Disease
A Phase 1 study, sponsored by La Jolla Pharmaceutical Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT01717248: Completed Phase 1 study, sponsored by La Jolla Pharmaceutical Company.
NCT01717248 is a Phase 1 study that has completed, run by La Jolla Pharmaceutical Company. The registered enrollment target is 29 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01717248, a Phase 1 study, has completed, sponsored by La Jolla Pharmaceutical Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of GCS-100 as a treatment for chronic kidney disease.
Primary Outcome
Assess overall safety of rising dose of GCS-100 in CKD patients
Interventions
- DRUG GCS-100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
What the finished NCT01717248 record still lists
NCT01717248 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 1 intervention - of which GCS-100 is the first listed.
NCT01717248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01717248 about?
NCT01717248 is a clinical study titled "Safety Study of GCS-100 to Treat Chronic Kidney Disease". The purpose of this study is to evaluate the safety of GCS-100 as a treatment for chronic kidney disease.
What is the current status of trial NCT01717248?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2013-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01717248?
The interventions under investigation include: GCS-100 (DRUG).
Who is sponsoring clinical trial NCT01717248?
This trial is sponsored by La Jolla Pharmaceutical Company, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01717248's enrollment target sits among peer trials
29 1440th of 2000 higher than 554 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia